financetom
Business
financetom
/
Business
/
Atossa Therapeutics Doses First Patient in Breast Cancer Therapy Study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atossa Therapeutics Doses First Patient in Breast Cancer Therapy Study
Aug 21, 2024 2:31 PM

09:08 AM EDT, 08/21/2024 (MT Newswires) -- Atossa Therapeutics ( ATOS ) said Wednesday that it had dosed the first patient in a trial evaluating its experimental drug, (Z)-endoxifen, in combination with Eli Lilly's ( LLY ) abemaciclib as a neoadjuvant treatment for certain high-risk breast cancer patients.

The study, which is part of the I-SPY network, will involve around 80 participants divided into two 40-participant cohorts and is expected to provide data by 2026.

The trial will be conducted by Atossa and Quantum Leap Healthcare Collaborative, with Atossa and Eli Lilly ( LLY ) supplying their respective drugs, Atossa said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China tells telecom carriers to phase out foreign chips in blow to Intel, AMD - WSJ
China tells telecom carriers to phase out foreign chips in blow to Intel, AMD - WSJ
Apr 12, 2024
April 12 (Reuters) - Chinese officials had earlier this year directed the nation's largest telecom carriers to phase out foreign processors that are core to their networks by 2027, a move which would hit American chip giants Intel ( INTC ) and Advanced Micro Devices ( AMD ), the Wall Street Journal reported on Friday. (Reporting by Akanksha Khushi in...
Provident Financial Services, Lakeland Bancorp Say Federal Reserve Approved Merger
Provident Financial Services, Lakeland Bancorp Say Federal Reserve Approved Merger
Apr 12, 2024
04:51 AM EDT, 04/12/2024 (MT Newswires) -- Provident Financial Services ( PFS ) and Lakeland Bancorp ( LBAI ) said late Thursday the Federal Reserve board has approved their proposed merger, completing the regulatory approvals required to close the deal. The companies said they expect to close the merger in Q2, subject to the completion of certain subordinated debt issuance...
Update: Constellation Brands' Fiscal Q4 Non-GAAP Earnings, Net Sales Beat Gets Bullish Thumbs-up From D.A. Davidson
Update: Constellation Brands' Fiscal Q4 Non-GAAP Earnings, Net Sales Beat Gets Bullish Thumbs-up From D.A. Davidson
Apr 12, 2024
04:36 AM EDT, 04/12/2024 (MT Newswires) -- (Updates with analyst comments in the first and last five paragraphs.) Constellation Brands' ( STZ ) free cash flow growth will be driven by steady market share gains in its beer business and margin expansion from low-end wine divestitures, according to a note from D.A. Davidson late Thursday following the company's fiscal Q4...
Transocean Prices $1.8 Billion Debt Offerings
Transocean Prices $1.8 Billion Debt Offerings
Apr 12, 2024
04:48 AM EDT, 04/12/2024 (MT Newswires) -- Transocean ( RIG ) on Thursday priced an upsized private offering of $900 million of senior notes due 2029 at 8.25% and $900 million of senior notes due 2031 at 8.5%. The offering is expected to close on or about April 18, subject to customary closing conditions. The Steinhausen, Switzerland-based company intends to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved